{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:23:56Z","timestamp":1773087836561,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Institutes of Health Research Strategy for Patient Oriented Research"},{"name":"SPOR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is caused primarily by mutations of two genes, PKD1 and PKD2. In the presence of a positive family history of ADPKD, genetic testing is currently seldom indicated as the diagnosis is mostly based on imaging studies using well-established criteria. Moreover, PKD1 mutation screening is technically challenging due to its large size, complexity (i.e. presence of six pseudogenes with high levels of DNA sequence similarity) and extensive allelic heterogeneity. Despite these limitations, recent studies have delineated a strong genotype\u2013phenotype correlation in ADPKD and begun to unravel the role of genetics underlying cases with atypical phenotypes. Furthermore, adaptation of next-generation sequencing (NGS) to clinical PKD genetic testing will provide a high-throughput, accurate and comprehensive screen of multiple cystic disease and modifier genes at a reduced cost. In this review, we discuss the evolving indications of genetic testing in ADPKD and how NGS-based screening promises to yield clinically important prognostic information for both typical as well as unusual genetic (e.g. allelic or genic interactions, somatic mosaicism, cystic kidney disease modifiers) cases to advance personalized medicine in the era of novel therapeutics for ADPKD.<\/jats:p>","DOI":"10.1093\/ndt\/gfy261","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T03:15:18Z","timestamp":1532574918000},"page":"1453-1460","source":"Crossref","is-referenced-by-count":40,"title":["Evolving role of genetic testing for the clinical management of autosomal dominant polycystic kidney disease"],"prefix":"10.1093","volume":"34","author":[{"given":"Matthew B","family":"Lanktree","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioan-Andrei","family":"Iliuta","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirreza","family":"Haghighi","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Song","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"York","family":"Pei","sequence":"first","affiliation":[{"name":"Division of Nephrology, University Health Network and University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"2020070205540112700_gfy261-B1","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2020070205540112700_gfy261-B2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2020070205540112700_gfy261-B3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nature03187","article-title":"The sequence and analysis of duplication-rich human chromosome 16","volume":"432","author":"Martin","year":"2004","journal-title":"Nature"},{"key":"2020070205540112700_gfy261-B4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1681\/ASN.2006121387","article-title":"Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B6","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B7","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"2020070205540112700_gfy261-B8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2011101032","article-title":"Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing","volume":"23","author":"Rossetti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.2015060648","article-title":"Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease","volume":"27","author":"Hwang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B10","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1681\/ASN.2016090938","article-title":"Polycystic kidney disease without an apparent family history","volume":"28","author":"Iliuta","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B11","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/ki.2008.485","article-title":"Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome","volume":"74","author":"Consugar","year":"2008","journal-title":"Kidney Int"},{"key":"2020070205540112700_gfy261-B12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD Score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monallelic mutations to DNAJB11 cause atypical autosomal dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2020070205540112700_gfy261-B14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2020070205540112700_gfy261-B15","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1172\/JCI90129","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest"},{"key":"2020070205540112700_gfy261-B16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ejhg.2015.86","article-title":"LRP5 variants may contribute to ADPKD","volume":"24","author":"Cnossen","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2020070205540112700_gfy261-B17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"2020070205540112700_gfy261-B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ki.2011.370","article-title":"A missense mutation in PKD1 attenuates the severity of renal disease","volume":"81","author":"Pei","year":"2012","journal-title":"Kidney Int"},{"key":"2020070205540112700_gfy261-B19","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","article-title":"Family history of renal disease severity predicts the mutated gene in ADPKD","volume":"20","author":"Barua","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B21","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2014101051","article-title":"Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease","volume":"27","author":"Audrezet","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B22","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"2020070205540112700_gfy261-B23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/318188","article-title":"Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease","volume":"68","author":"Pei","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2020070205540112700_gfy261-B25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","article-title":"Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy","volume":"49","author":"Losekoot","year":"2012","journal-title":"J Med Genet"},{"key":"2020070205540112700_gfy261-B26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14737159.2017.1358088","article-title":"Molecular diagnosis of autosomal dominant polycystic kidney disease","volume":"17","author":"Song","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2020070205540112700_gfy261-B29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.tig.2015.03.013","article-title":"Somatic mosaicism: implications for disease and transmission genetics","volume":"31","author":"Campbell","year":"2015","journal-title":"Trends Genet"},{"key":"2020070205540112700_gfy261-B30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2369-14-59","article-title":"Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele","volume":"14","author":"Reiterova","year":"2013","journal-title":"BMC Nephrol"},{"key":"2020070205540112700_gfy261-B31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2020070205540112700_gfy261-B32","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1093\/ndt\/gft253","article-title":"Molecular genetics of familial hematuric diseases","volume":"28","author":"Deltas","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2020070205540112700_gfy261-B33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tem.2016.02.002","article-title":"Apolipoprotein L1 and kidney disease in African Americans","volume":"27","author":"Friedman","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"2020070205540112700_gfy261-B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"2020070205540112700_gfy261-B35","doi-asserted-by":"crossref","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"2020070205540112700_gfy261-B36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ki.2015.28","article-title":"Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2013A KDIGO consensus report","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"},{"key":"2020070205540112700_gfy261-B37","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2","volume":"28","author":"Cabezas","year":"2017","journal-title":"JASN"},{"key":"2020070205540112700_gfy261-B38","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1220967","article-title":"Medicine whole-genome sequencing: the new standard of care?","volume":"336","author":"Brunham","year":"2012","journal-title":"Science"},{"key":"2020070205540112700_gfy261-B39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrneph.2014.95","article-title":"Next-generation sequencing for research and diagnostics in kidney disease","volume":"10","author":"Renkema","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2020070205540112700_gfy261-B40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-0835-6_21","article-title":"Dealing with pseudogenes in molecular diagnostics in the next-generation sequencing era","volume":"1167","author":"Claes","year":"2014","journal-title":"Methods Mol Biol"},{"key":"2020070205540112700_gfy261-B41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jmoldx.2013.10.005","article-title":"Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing","volume":"16","author":"Tan","year":"2014","journal-title":"J Mol Diagn"},{"key":"2020070205540112700_gfy261-B42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mgg3.82","article-title":"Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing","volume":"2","author":"Trujillano","year":"2014","journal-title":"Mol Genet Genomic Med"},{"key":"2020070205540112700_gfy261-B43","doi-asserted-by":"crossref","first-page":"e0116680","DOI":"10.1371\/journal.pone.0116680","article-title":"An efficient and comprehensive strategy for genetic diagnostics of polycystic kidney disease","volume":"10","author":"Eisenberger","year":"2015","journal-title":"PLoS One"},{"key":"2020070205540112700_gfy261-B44","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/ejhg.2016.48","article-title":"Whole-genome sequencing overcomes pseudogene homology to diagnose autosomal dominant polycystic kidney disease","volume":"24","author":"Mallawaarachchi","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2020070205540112700_gfy261-B45","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1172\/JCI67273","article-title":"Altered trafficking and stability of polycystins underlie polycystic kidney disease","volume":"124","author":"Cai","year":"2014","journal-title":"J Clin Invest"},{"key":"2020070205540112700_gfy261-B46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ajhg.2014.04.009","article-title":"Return of genomic results to research participants: the floor, the ceiling, and the choices in between","volume":"94","author":"Jarvik","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2020070205540112700_gfy261-B47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/gim.2016.190","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics","volume":"19","author":"Kalia","year":"2017","journal-title":"Genet Med"},{"key":"2020070205540112700_gfy261-B48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/9\/1453\/33455958\/gfy261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/9\/1453\/33455958\/gfy261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T09:54:21Z","timestamp":1593683661000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/9\/1453\/5085076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,27]]},"published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy261","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,9]]},"published":{"date-parts":[[2018,8,27]]}}}